APOA5 抗体 (N-Term)
Our Local Distributor
北京 101111
Quick Overview for APOA5 抗体 (N-Term) (ABIN5535201)
抗原
See all APOA5 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 22-52, N-Term
-
纯化方法
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
免疫原
- This APOA5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 22-52 amino acids from the N-terminal region of human APOA5.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 2 mg/mL
-
缓冲液
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
别名
- APOA5
-
背景
- APOA5 is an apolipoprotein and an important determinant of plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury.
-
分子量
- 41 kDa
-
基因ID
- 116519
-
UniProt
- Q6Q788
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
抗原
-